Journal article
Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer
Abstract
OBJECTIVES: The independent prognostic effect of comorbidities on outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) is unclear. We sought to determine whether the Charlson comorbidity index (CCI) and hypertension (HTN) are associated with overall survival (OS) independent of known clinical prognostic factors in mCRPC.
PATIENTS AND METHODS: A retrospective analysis was conducted on 221 patients with mCRPC treated with …
Authors
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao C-K; Sonpavde G
Journal
Urologic Oncology Seminars and Original Investigations, Vol. 32, No. 1, pp. 36.e27–36.e34
Publisher
Elsevier
Publication Date
1 2014
DOI
10.1016/j.urolonc.2013.02.015
ISSN
1078-1439
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAlgorithmsComorbidityDisease-Free SurvivalDocetaxelHumansHypertensionMaleMiddle AgedMultivariate AnalysisNeoplasm MetastasisPredictive Value of TestsPrognosisProportional Hazards ModelsProspective StudiesProstatic Neoplasms, Castration-ResistantRetrospective StudiesSurvival AnalysisTaxoidsTreatment Outcome